Business Context and Reporting Period
This Form 8-K was filed by WellPoint, Inc. (now Elevance Health, Inc.) on September 10, 2013. The report serves as a Regulation FD disclosure regarding upcoming meetings with securities analysts and investors scheduled between September 10, 2013, and September 27, 2013.
Key Financial Metrics and Guidance
Management reaffirmed its full-year 2013 net income per share guidance. The filing provides specific targets for both reported and adjusted metrics, excluding investment gains or losses beyond those recorded in the first six months of 2013.
- Full Year 2013 Net Income Per Diluted Share: At least $7.89
- Full Year 2013 Adjusted Net Income Per Diluted Share: At least $8.00
- Net Adjustment Items: $0.11 per share (included in the reported guidance)
The filing does not provide specific values for total revenue, operating cash flow, total debt, or liquidity ratios for the period.
Material Changes and Unusual Items
The guidance includes specific adjustments for unusual items and costs incurred during the first three quarters of 2013:
- Expenses related to early retirement of debt (Q3 2013): $0.32 per share
- Tax benefits from a favorable tax election (Q3 2013): ($0.21) per share
- Acquisition and integration related costs (First 6 months 2013): $0.05 per share
- Net realized gains on investments (First 6 months 2013): ($0.15) per share
- Other-than-temporary impairment losses on investments (First 6 months 2013): $0.10 per share
Outlook, Risks, and Contingencies
Management's outlook is subject to significant risks and uncertainties, including:
- Regulatory Environment: Impact of the Patient Protection and Affordable Care Act and potential changes in government participation or taxation.
- Acquisition Integration: Risks associated with integrating AMERIGROUP Corporation, including potential delays, higher costs, or lower-than-expected revenues.
- Market and Operational Risks: Trends in healthcare costs, provider contracting, competitor pricing, and enrollment changes.
- Financial Risks: Potential downgrades in financial strength ratings, litigation outcomes, and investment portfolio performance.
- Operational Disruptions: Risks related to information systems, data security, and compliance with the Express Scripts, Inc. agreement.
Investor Verification Checklist
- Verify the actual full-year 2013 net income per share against the $7.89 guidance.
- Confirm the final impact of the AMERIGROUP Corporation acquisition on operating costs and synergies.
- Review subsequent filings for updates on the early retirement of debt expenses and tax election benefits.
- Monitor regulatory developments regarding the Affordable Care Act and their impact on premium rates.
- Check for any material changes in investment portfolio performance or impairment losses beyond the first six months of 2013.